Rangwala, Reshma <br/><br/>
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.  [electronic resource] 

 -  Autophagy  Aug 2014 
 - 1369-79 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1554-8635 
<br/><br/><label>Standard No.: </label>10.4161/auto.29118  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Autophagy--drug effects<br/>Dacarbazine--adverse effects<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Hydroxychloroquine--adverse effects<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasm Staging<br/>Neoplasms--drug therapy<br/>Temozolomide<br/>Treatment Outcome